Ausgabe 1/2004
Inhalt (49 Artikel)
Meeting report
Infliximab [Remicade]: warning information added to US label
Clinical study
Epirubicin + paclitaxel: no increase in cardiotoxicity
Clinical study
Increased epirubicin dose tolerable in adjuvant FEC therapy
Incidence study
Long-term simvastatin treatment not associated with cancer risk
Clinical study
Antidepressant-associated manic conversion risk age-related
Clinical study
Gemcitabine associated with decreased diffusion capacity
Clinical study
Tramadol/warfarin interaction related to CYP2D6 activity
Clinical study
HRT: elevated risk of all breast cancer prognostic types?
Clinical study
Levacecarnine improves antiretroviral-induced neuropathy
Case report
Alendronic acid
Case reports
Anthrax vaccine
Case report
Antivenins
Case report
Benzyl alcohol
Case reports
Cabergoline/pergolide
Case report
Capecitabine
Case report
Carbamazepine
Case report
Carbamazepine interaction
Case report
Celecoxib
Case report
Celecoxib interaction
Case report
Chloroquine
Case report
Dalteparin sodium
Case report
Digoxin interaction
Case report
Doxifluridine
Case report
Efavirenz/lamivudine/zidovudine
Case report
Estradiol
Case report
Fludarabine
Case report
Flutamide
Case report
Indinavir
Case report
Irinotecan
Case report
Leuprorelin withdrawal
Case report
Levofloxacin
Case report
Lithium
Correspondence
Lithium
Case report
Mirtazapine
Case report
Mirtazapine
Case report
Olanzapine
Case report
Olanzapine
Case report
Poliomyelitis vaccine inactivated
Case report
Sotalol
Case report
Sulphan blue
Case report
Tacrolimus
Case report
Tetracycline
Case report
Trofosfamide
Case report